1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. CEREBROSPINAL FLUID (CSF) MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. CSF Shunts
5.3. External Drainage System
6. CEREBROSPINAL FLUID (CSF) MARKET BY END-USER
6.1. Introduction
6.2. Pediatric
6.3. Adult
6.4. Geriatric
7. CEREBROSPINAL FLUID (CSF) MARKET BY INDUSTRY
7.1. Introduction
7.2. Hospital
7.3. Clinics
7.4. Others
8. CEREBROSPINAL FLUID (CSF) MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Medtronic
10.2. Integra LifeSciences
10.3. Johnson & Johnson MEDTECH
10.4. B. Braun Melsungen AG
10.5. Spiegelberg GmbH & Co. KG (Acquired by SHS Medizintechnik Holding GmbH)
10.6. Sophysa (A subsidiary of tkb group)
10.7. Natus Medical Incorporated (Acquired by ArchiMed Group)
10.8. Argi Grup
10.9. Moller Medical GMBH
10.10. Delta Surgical
10.11. Wellong Instruments Co., Ltd.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES